Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy

Area of Science:

• Immunology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Autoimmune diseases involve immune system dysregulation and self-reactive immune cell expansion.
• Mesenchymal stem cells (MSCs) exhibit immune-modulatory and immunosuppressive capacities.
• MSCs may be defective in autoimmune conditions, presenting a therapeutic target.

Purpose of the Study:

• To review recent advancements in the biology of MSCs and hematopoietic stem cells (HSCs).
• To explore the potential therapeutic applications of MSCs and HSCs in managing autoimmune diseases.
• To discuss the role of stem cell defects in the etiology of autoimmune disorders.

Main Methods:

• Literature review of studies on MSC and HSC biology and therapy.
• Analysis of in vitro and in vivo data on MSC immune-modulatory effects.
• Examination of outcomes from hematopoietic stem cell transplantation (HSCT) in autoimmune patients.

Main Results:

• MSCs demonstrate significant immune-modulatory and immunosuppressive properties.
• Evidence suggests MSCs may be impaired in patients with autoimmune diseases.
• Autologous HSCT has been successfully used in over 1500 patients for severe autoimmune diseases.

Conclusions:

• MSCs hold promise as a potential therapy for autoimmune diseases due to their immune-modulating abilities.
• Defects in HSCs may contribute to autoimmune disease development, supporting HSCT rationale.
• HSCT offers a strategy to ablate aberrant immune systems and re-establish self-tolerance.